Arkolith/Insider Trading/TBPH/Form 4

Winningham Rick E

CHIEF EXECUTIVE OFFICER, DirectorTheravance Biopharma, Inc. (TBPH) · full profile →Form 4 · filed Jun 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2025Gift(G)10K—$014K
Jun 13, 2025Gift(G)10K—$01.8M

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-017585) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML